No Data
No Data
Hims & Hers Health Discontinues Dermatology Business Apostrophe
Press Release: Define Ventures Appoints Carolyn Magill as Venture Partner
Citi Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $27
Hims & Hers Health Options Spot-On: On March 10th, 87,583 Contracts Were Traded, With 687.57K Open Interest
Sector Update: Consumer Stocks Flat to Lower Premarket Monday
DoorDash, TKO, Williams-Sonoma Set to Join S&P 500